Table 8 Prevalence of metabolic syndrome in Iran based on JIS criteria
From: Prevalence of metabolic syndrome and its components in Iran: an updated meta-analysis
Criteria | Categories | No. study | Pooled prevalence (% 95 CI) | Heterogeneity assessment between studies | Publication bias assessments | ||||
|---|---|---|---|---|---|---|---|---|---|
I2 | P value | B | SE | P value | |||||
JIS | Overall | 11 | 37% (28 − 47%) | 99.72% | < 0.001 | 3.10 | 2.734 | 0.2568 | |
Sex | Female | 5 | 34% (16 − 55%) | 99.88% | < 0.001 | 1.37 | 7.478 | 0.8544 | |
Male | 4 | 42% (36 − 48%) | 97.24% | < 0.001 | 0.65 | 3.864 | 0.8670 | ||
Age | 30–65 | 10 | 41% (36 − 46%) | 98.80% | < 0.001 | 3.10 | 2.734 | 0.2568 | |
Province | Tehran | 3 | 25% (9 − 46%) | 3.10 | 2.734 | 0.2568 | |||
Yazd | 1 | 70% (65 − 74%) | |||||||
Qazvin | 2 | 38% (36 − 40%) | |||||||
Isfahan | 3 | 36% (32 − 40%) | |||||||
Mazandaran | 1 | 38% (37 − 39%) | |||||||
multi province | 1 | 48% (28 − 47%) | |||||||
Components | WC | 4 | 49% (28 − 70%) | 99.89 | < 0.001 | -0.24 | 12.187 | 0.9841 | |
IFG | 4 | 29% (22 − 36%) | 99.18% | < 0.001 | 1.78 | 5.592 | 0.7499 | ||
TG | 4 | 40% (33 − 48%) | 99.18% | < 0.001 | 3.42 | 3.709 | 0.3567 | ||
HDL | 4 | 67% (63 − 72%) | 97.91% | < 0.001 | -4.05 | 2.954 | 0.1703 | ||
BP | 4 | 31% (22 − 42%) | 99.59% | < 0.001 | -7.21 | 4.052 | 0.0752 | ||